Mathes Company’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
Mathes Company's BCAT Position: Q3 2026 in Review
Mathes Company reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 34% in Q3 2026, selling an estimated $239K and leaving 30,500 shares worth $418K. The position accounts for 0.14% of the portfolio, ranked #82.
Mathes Company first reported a position in BCAT in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.66M in Q4 2024. 119 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.
- Mathes Company held 30,500 shares of BlackRock Capital Allocation Term Trust worth $418K as of Q3 2026.
- Mathes Company sold 15,500 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $239K.
- BlackRock Capital Allocation Term Trust made up 0.14% of Mathes Company's portfolio in Q3 2026, its #82 holding.
- Mathes Company first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 24 quarters since.
- Mathes Company's BlackRock Capital Allocation Term Trust position peaked at $1.66M in Q4 2024.
- 119 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.
Based on Mathes Company's 13F filing for Q3 2026, filed 16 Nov 2026.